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A B S T R A C T
Current treatments for seizures induced by organophosphates do not protect sufﬁciently against
progressive neurodegeneration or delayed cognitive impairment. Developing more effective therapeutic
approaches has been challenging because the pathogenesis of these delayed consequences is poorly
deﬁned. Using magnetic resonance imaging (MRI), we previously reported brain lesions that persist for
months in a rat model of acute intoxication with the OP, diisopropylﬂuorophosphate (DFP). However, the
early spatiotemporal progression of these lesions remains unknown. To address this data gap, we used in
vivo MRI to longitudinally monitor brain lesions during the ﬁrst 3 d following acute DFP intoxication.
Adult male Sprague Dawley rats acutely intoxicated with DFP (4 mg/kg, sc) were MR imaged at 6, 12, 18,
24, 48, 72 h post-DFP, and their brains then taken for correlative histology to assess neurodegeneration
using FluoroJade C (FJC) staining. Acute DFP intoxication elicited moderate-to-severe seizure activity. T2-
weighted (T2w) anatomic imaging revealed prominent lesions within the thalamus, piriform cortex,
cerebral cortex, hippocampus, corpus striatum, and substantia nigra that corresponded to neuro-
degeneration, evident as bands of FJC positive cells. Semi-quantitative assessment of lesion severity
demonstrated signiﬁcant regional variation in the onset and progression of injury, and suggested that
lesion severity may be modulated by isoﬂurane anesthesia. These results imply that the timing of
therapeutic intervention for attenuating brain injury following OP intoxication may be regionally
dependent, and that longitudinal assessment of OP-induced damage by MRI may be a powerful tool for
assessing therapeutic response.
© 2017 Elsevier B.V. All rights reserved.
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Organophosphate anticholinesterases (OPs) are potent neu-
rotoxicants that are widely used as pesticides, and have been
developed as nerve agents (e.g., sarin and soman) (Gupta,
2006). OP intoxication is estimated to cause over 170,000
deaths and 1 million life-threatening intoxications each year
(Gunnell et al., (2007), Mew et al., (2017)). These statistics,
coupled with the documented use of OP nerve agents by
governments (Dolgin, 2013) and terrorist organizations (Morita
et al., 1995), identify OPs as a serious public health threat
(Gunnell and Eddleston, (2003), Jett, (2007), Pereira et al.,
(2014)). Acute intoxication with high doses of OPs quickly leads
to irreversible inhibition of acetylcholinesterase within the
brain and periphery, which causes cholinergic crisis and can
B.A. Hobson et al. / NeuroToxicology 66 (2018) 170–178 171trigger seizures that rapidly progress to status epilepticus (SE)
(Chen, (2012), Collombet, (2011), Lowenstein et al., (1999)).
Preclinical studies of OP-induced SE have demonstrated the
development of profound neuropathology, including extensive
neuronal necrosis and neuroinﬂammation, in the days following
OP intoxication that can persist for weeks to months post-
exposure (Aroniadou-Anderjaska et al., (2016), Chen, (2012),
Collombet, (2011), Flannery et al., (2016), Li et al., (2011), Liu
et al., (2012), Siso et al., (2017)). Clinical case studies and
preclinical models also indicate lasting neurologic consequences,
including brain atrophy, loss of cognitive function, memory
deﬁcits, and epilepsy that develops after a latent period
following OP-induced SE (Aroniadou-Anderjaska et al., (2016),
Chen, (2012), Flannery et al., (2016), Hobson et al., (2017), Miyaki
et al., (2005)).
Current antidotes are of limited use in treating acute OP
intoxication because, unless administered within minutes after
exposure, they neither effectively terminate seizures nor prevent
the ensuing neuropathology and chronic neurological consequen-
ces (Collombet, (2011), McDonough et al., (2010)). There is,
therefore, an urgent need for more effective treatments. Electro-
encephalographic and neuropathological data suggest that the
hours following acute intoxication are likely critical therapeutic
windows for mitigating subsequent morbidity (Kaur et al., 2014).
However, the optimal timing for the delivery of potential
therapeutics remains poorly deﬁned, due in part to: (i) a paucity
of systematic, longitudinal data on the progression of OP
intoxication-induced brain damage; and (ii) a limited understand-
ing of the degree to which structurally diverse OP nerve agents and
pesticides share common spatiotemporal proﬁles of injury.
Addressing these challenges using classic, terminal histologic
methods can be time-consuming and cost-prohibitive because of
the number of animals required and the extensive tissue
processing needed for comprehensive spatiotemporal assessment
of the brain. One strategy for overcoming these challenges is to use
non-invasive imaging modalities, such as magnetic resonance
imaging (MRI).
MRI has been a valuable tool for studying the consequences of
seizures (Mendes and Sampaio, (2016), Milligan et al., (2009)).
Using MRI, the rodent brain can be noninvasively and repeatedly
interrogated, enabling detailed spatiotemporal mapping of brain
injury within a single animal. In addition to reducing animal
numbers, the collection of longitudinal data increases statistical
power and allows animals with varying response patterns to be
readily identiﬁed. While MRI has been used extensively to study
preclinical seizure models, there are a limited number of
publications describing the use of MRI to assess seizure-induced
brain injury in preclinical models of acute OP intoxication (Bhagat
et al., (2001), Bhagat et al., (2005), Carpentier et al., (2008),
Gullapalli et al., (2010), Hobson et al., (2017), Rosman et al., (2012),
Shrot et al., (2012), Shrot et al., (2015), Testylier et al., (2007)). We
recently reported a correlative histologic and MRI-based charac-
terization of a rat model of acute intoxication with the OP pesticide,
diisopropylﬂuorophosphate (DFP) (Hobson et al., 2017, Siso et al.,
2017). Similar to OP nerve agents, DFP rapidly produces SE, as
determined by electroencephalography (Pouliot et al., 2016), and
generates progressive neuronal necrosis (Siso et al., 2017), neuro-
inﬂammation (Flannery et al., 2016), and cognitive impairment
(Brewer et al., (2013), Flannery et al., (2016)). In our previous MRI
studies, we characterized the progression of brain lesions
beginning at 3 d out to 1 month post-DFP intoxication. However,
there are no MRI data published regarding lesion development
during the ﬁrst 3 d following DFP intoxication. While previous MRI
studies in rodent models of acute intoxication with OP nerve
agents have detected lesions as early as 3 h post-intoxication
(Carpentier et al., 2008, Shrot et al., 2012), considerable variation ininjury has been reported at these early time points. It is unclear,
however, whether these disparate ﬁndings reﬂect differences in
the intoxicating OP (soman vs. sarin) vs. differences in the time at
which images were collected post-exposure. Distinguishing
between these possibilities is difﬁcult given that few studies have
examined more than one time point during the ﬁrst 24 h following
OP intoxication (Bhagat et al., 2005).
The objective of the current study was to address the gap in
knowledge regarding the progression of brain injury during early
time points post-exposure after OP-induced SE by generating a
spatiotemporal proﬁle of brain lesions detected during the ﬁrst
72 h following DFP exposure by anatomic, T2-weighted (T2w) MR
imaging.
2. Methods
2.1. Animals and DFP exposures
All animals were housed in facilities fully accredited by AAALAC
Internatonal, and all studies were performed with regard to the
alleviation of pain and suffering under protocols approved by the
University of California-Davis Institutional Animal Care and Use
Committee. Adult male Sprague Dawley rats (250–280 g; Charles
River Laboratories, Hollister, CA) were housed individually in
standard plastic shoebox cages under controlled environmental
conditions (22  2 C, 40–50% humidity) with a normal 12 h light/
dark cycle. Food and water were provided ad libitum.
DFP (> 90% purity as determined by 1H NMR spectroscopy)
was purchased from Sigma Chemical Company (Saint Louis, MO)
and upon opening a sealed vial, was aliquoted and stored at
80 C. Under these conditions, it has been shown that DFP is
stable for at least 400 days (Heiss et al., 2016). DFP was diluted
with sterile, ice-cold phosphate buffered saline (PBS) within
5 min of administration to unanesthetized rats at 4 mg/kg in a
total volume of 300 ml via sc injection. In addition, animals
received 0.1 mg/kg pyridostigmine bromide (TCI America, Port-
land, OR), im, 30 min prior to DFP administration and immedi-
ately following DFP exposure, rats were injected with atropine
sulfate (Sigma Chemical Company) at 2.0 mg/kg, im, and
pralidoxime (2-PAM, Sigma Chemical Company) at 25 mg/kg in
saline, im. These treatments signiﬁcantly reduce mortality by
blocking the peripheral parasympathomimetic clinical signs
associated with acute OP intoxication (Kim et al., 1999). This
dosing paradigm has been shown to reliably produce sustained
seizures in > 90% of injected animals with > 75% survival of
seizing animals at 24 h post-DFP injection (Pessah et al., 2016). At
4 h post-exposure, animals were injected sc with 10 ml of 5%
dextrose in saline to replace lost ﬂuids and to prevent
hypoglycemia, and returned to their home cages where they
were provided with rat chow softened in water for the duration of
the study.
2.2. Scoring seizure behavior
Seizure severity was quantiﬁed as previously described
(Hobson et al., (2017), Siso et al., (2017)) using a ﬁve-point
cholinergic toxicity scale based on the following behavioral
criteria: 0, no clinical signs; 1, salivation, urination, lacrimation
and/or defecation (SLUD); 2, muscle fasciculations and tremors;
3, forelimbs clonus; 4, rearing and hindlimb clonus; 5, rearing
with falling and loss of righting reﬂex. Repeated scores of three
and above were shown previously in a preclinical model of
acute DFP intoxication to correspond to SE, deﬁned as sustained
seizure activity detected by electroencephalography that persists
for more than 5 min (Deshpande et al., (2010), Pouliot et al.,
(2016)). Seizure behavior was scored at 5 min intervals from 0 to
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to 240 min post-DFP (Fig. S1 in Supplementary material). Of a
total of twenty injected animals, the twelve animals with the
highest average cholinergic toxicity scores over 4 h post-DFP
injection were selected for the MRI study (individual animal
seizure scores for all 20 animals are provided in Table S1 in
Supplementary material).
2.3. in vivo magnetic resonance imaging and analysis
MRI scans were performed at the Center for Molecular and
Genomic Imaging, using a Bruker Biospec 70/30 (7T) preclinical
MR scanner (Bruker BioSpin MRI, Ettlingen, Germany) equipped
with a 116-mm internal diameter B-GA12S gradient (450 mT/m,
4500 T/m/s), a 72-mm internal diameter linear transmit coil,
and a four-channel, rat-brain phased array in crossed coil
conﬁguration for signal reception. Images were acquired and
reconstructed using Paravision 5.1 (Bruker BioSpin MRI).
Multislice, T2w, Rapid Acquisition with Repeated Echoes (RARE)
transaxial images were collected over 10 min, using the
following parameters: repetition time (TR) = 6100 ms; effective
echo time (TE) = 60 ms; RARE factor = 8; averages = 4; ﬁeld of
view (FOV) = 35  25 mm2, in-plane data matrix = 280  200,
resulting in an
in-plane pixel resolution of 0.125  0.125 mm2 for 44 slices
with a 0.5-mm thickness, spanning approximately 8.0 to
14.0 mm bregma according to Paxinos and Watson’s The Rat
Brain in Stereotaxic Coordinates (Paxinos, 2007). Animals were
randomly divided into two groups prior to imaging: Group 1
animals, which were imaged at 6, 18, 48, and 72 h post-DFP
injection; and Group 2 animals, which were imaged at 12, 24,
and 72 h post-DFP injection. To account for the 90 min required
to complete imaging of the six animals within each group,
scanning began 45 min prior to, and ended 45 min after nominal
time points (e.g., the imaging time for Group 1 at the nominal
time point of 6 h was 6  0.75 h). A vehicle control animal
similarly treated with pyridostigmine bromide, atropine and 2-
PAM but injected with 300 ml of PBS in place of DFP, was imaged
at 72 h to provide an anatomic reference and baseline for scoring
lesion severity, as discussed below. Immediately prior to
imaging, animals were placed in a Plexiglas induction chamber
and anesthetized with isoﬂurane/O2 (Piramal Healthcare, Beth-
lehem PA), 2.0-3.0% vol/vol for 3–5 min. After induction, animals
were secured in a custom stereotactic head restraint, anesthesia
was reduced to 1.0-2.0% vol/vol, and animals were then placed in
the MR scanner (2–5 min). Once in the scanner, a body
temperature of 37 C and respiration rate of 50–70 breaths/
min were maintained using warm air and adjustment of
isoﬂurane levels. Temperature and respiration rate were moni-
tored using SAII 1025T small-animal monitoring equipment
(Small Animal Instruments, Inc., Stony Brook, NY). Animals were
in the scanner for 10–15 min for image localization and RARE
scans.
Delineation of brain regions was guided by Paxinos and
Watson’s The Rat Brain in Stereotaxic Coordinates (Paxinos, 2007),
and eight regions were agreed upon prior to scoring of lesion
severity. The axial extent of assessed brain regions, deﬁned as the
“anterior start distance from bregma”/”extent in mm”, were:
cerebral cortex, 2.0/7.0; hippocampus, 2.5/3.5; lateral ventricles,
2.0/7.0; piriform cortex, 2.0/5.0; caudate putamen, 2.0/3.5; globus
pallidus, 0.5/1.5; substantia nigra, 5.0/1.0; and thalamus (medial
and dorsolateral), 1.5/2.5.
Changes induced by acute DFP-intoxication, hereafter referred
to as lesions, were identiﬁed based on their hyperintensity relative
to neighboring tissue and the corresponding brain region on T2 w
images of historical vehicle controls 72 h post-exposure (Hobsonet al., 2017). Regional lesion severity was scored by two
independent observers blinded to seizure severity, using a
multiparametric scale ranging from 0 to 3, according to the
following criteria: 0, no hyperintensity; 1, hyperintensity the
extent of which was <50% of assessed region of interest (ROI); 2,
either stark hyperintensity with distinct discrete borders, or
hyperintensity the extent of which was >50% of the assessed ROI;
3, both stark hyperintensity with distinct discrete borders and
hyperintensity that covered > 50% of the ROI. Lateral ventriculo-
megaly was scored based on the following visual criteria: 0, no
ventricular enlargement, 1, bilateral ventricular enlargement < 2
times vehicle control reference; 2, unilateral enlargement  2
times vehicle control reference; 3, bilateral enlargement  2 times
vehicle control reference. Representative T2 w images illustrating
lesions scored according to these criteria are presented in the
Supplementary material (Fig. S2). Half-unit increments were used
when deﬁnitive integer scores were ambiguous. Lesions were
bilateral, but occasionally varied in severity between hemispheres.
This hemispheric variation was taken into account during the
scoring of lesion severity in which a single score was determined
for the combined hemispheres of a given brain region. Individual
scores between raters differed by  1.0, with an average difference
between scores of 0.23  0.27 and overall inter-rater reliability of
0.745, as determined using Fleiss’s Kappa with linear weighting.
Final regional lesion severity scores used for statistical analyses
were the averages of the individual observer scores per region/by
animal/by time point. The lesion scoring data for the twelve
animals included in the MRI study are provided in the Supple-
mentary material (Table S2).
2.4. Histology
Brains were harvested at 3 d post-exposure from animals
deeply anesthetized with 4% isoﬂurane in oxygen, and subse-
quently perfused transcardially with 100 ml cold PBS at a rate of
15 ml/min using a Masterﬂex peristaltic pump (Cole Parmer,
Vernon Hills, IL) followed by 100 ml cold 4% paraformaldehyde
(aq). Brains were serially trimmed into 2.0-mm blocks, post-ﬁxed
in 4% paraformaldehyde (aq) at 4 C for 24 h, and then transferred
to 30% sucrose in PBS. Brains were stored in 30% sucrose at 4 C at
least until they had sunk to the bottom of the vial. Brain blocks
were embedded in O.C.T. compound (Sakura Finetek, Torrance, CA),
ﬂash frozen and then sectioned into 10-mm thick axial slices that
were stored at 80 C until further processed. To detect neuronal
degeneration, sections were labeled with FluoroJade C (FJC)
(Millipore, Billerica, MA), as previously described (Li et al.,
2011), with minor modiﬁcations. Brieﬂy, after air drying, sections
were washed with distilled water and then directly incubated in
0.03% potassium permanganate (KMnO4) (aq) for 10 min on a
shaker table, followed by distilled water for 2 min. Sections were
then incubated in a freshly prepared solution of 0.00015% FJC in
0.1% acetic acid (aq) for 10 min, rinsed in distilled water and then
dried at 50 C. Dried slides were cleared by immersion in xylene for
2 min before cover slipping in Permount (Fisher Scientiﬁc,
Hampton, NH).
2.5. Statistics
The primary outcome was the average of two independent
ratings of lesions in MR images across multiple regions of the brain
(cerebral cortex, hippocampus, thalamus, and piriform cortex)
over time, for each animal in two different cohorts of DFP-exposed
animals. Due to the repeated measures across regions and across
time for each animal, mixed-effects regression models were used
to assess the overall mean trajectories of lesion severity over time,
as well as differences by brain region and cohort. Time, in days
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(e.g., a ﬁxed effect) to capture the pattern of lesion severity over
time. The coefﬁcient for time may be interpreted as the average
change in lesion severity per day. Individual trajectories of animals
(Supplementary material, Fig. S3), as well as model diagnostics
including residual plots, indicated a quadratic association with
time. To account for this non-linearity, a term for time squared was
also included as a ﬁxed effect in the models, which taken together
with the term for time describes the quadratic pattern of lesion
severity. A negative coefﬁcient of time squared indicates a
“hill-like” pattern, while a positive coefﬁcient suggest a “valley-
like” pattern. Fixed effects for brain region and cohort were
included to assess the associations between brain region or cohort
and level of lesion severity. Further, interactions between region or
cohort and the time variables were assessed to evaluate the
differences in the temporal trends (quadratic pattern) by brain
region or cohort. The animal-speciﬁc random effect accounts for
unexplained biological heterogeneity, such that some animals may
inherently be more susceptible to lesions even after accounting for
the ﬁxed effects, such as brain region and cohort, while others may
be resistant to lesions.
Model building began with the full model considering all main
effects (such as brain region, cohort, time and time-squared) as
well as the interactions between brain region and cohort and the
time variables. Interactions were dropped individually and these
reduced models were compared to the full model using the Akaike
information criterion (smaller is better) until the Akaike informa-
tion criteria was no longer reduced. This ﬁnal model was then used
to characterize the spatiotemporal patterns of lesion severity by
group. Contrasts speciﬁcally comparing the two cohorts were
created and used to statistically test for differences between the
groups. 95% conﬁdence intervals for the slope (coefﬁcient for time)
and for the coefﬁcient of time-squared for each brain region wereFig. 1. T2w anatomic MR images depicting the spatiotemporal progression of brain l
hyperintensity compared to neighboring tissue, and a vehicle control reference scan. Gro
or 12, 24 and 72 h respectively. Note that Group 1 begins MR imaging 6 h prior to Group
indicate the positions of brain regions displaying hyperintense lesions at one or more t
Watson and Paxinos, The Rat Atlas in Stereotactic Coordinates (Paxinos, 2007).also obtained from the model. All analyses were conducted using
SAS version 9.4, and graphics were created in R, version 3.1.0.
3. Results
3.1. DFP intoxication produces robust seizures consistent with status
epilepticus
Consistent with our previous studies (Flannery et al., (2016),
Hobson et al., (2017), Siso et al., (2017)), acute DFP-intoxication
resulted in behavioral signs of seizure activity consistent with SE in
the twelve animals included in the MRI study. There was no
signiﬁcant difference in average cholinergic toxicity scores
between animals in Group 1 (2.99  0.13) vs. Group 2
(2.84  0.31) (the average cholinergic toxicity score for each
individual animal is provided in the Supplementary material,
Table S1). Behavioral signs of seizure attenuated to levels below
those suggestive of SE (cholinergic toxicity score  2) by the start of
imaging at 6 h post-exposure, and were back to vehicle control
levels by the initiation of imaging at 12 h post-exposure. The
survival rate was 92%, with one animal in Group 1 dying between
24 and 48 h post-DFP injection.
3.2. DFP intoxication results in progressive brain lesions detected by
T2 w MRI
MR imaging revealed bilateral lesions following acute DFP
intoxication. Lesions were characterized by T2w hyperintensity in
limbic brain regions (i.e., hippocampus, piriform cortex, thalamus,
amygdala, basal ganglia) and cerebral cortex (spanning the
complete somatosensory cortex, and portions of the motor,
auditory, and parietal and visual cortices) that varied both spatially
and temporally (Fig. 1). At ﬁrst appearance, lesions were localizedesions following acute DFP intoxication. Lesions were characterized by localized
up 1 and Group 2 images each represent a single animal imaged at 6, 18, 48 and 72 h,
 2. Across time points, images were selected to match bregma to  250 mm. Arrows
ime points following intoxication. Sagittal-view atlas reference was adapted from
Fig. 2. T2w anatomic MR images depicting brain regions with sporadic lesions across study animals. Images of lesions in the septal area, caudate putamen, globus pallidus,
and substantia nigra collected from Group 1 animals. The images displaying the substantia nigra and caudate putamen lesions are from the same animal at two separate time
points; the other images are each from separate animals.
Table 1
Summary of MRI lesion severity scores.
Time Post DFP (h) 6* 12** 18* 24** 48* 72***
Incidence Severity Incidence Severity Incidence Severity Incidence Severity Incidence Severity Incidence Severity
Hippocampus 0/6 n/a 4/6 0.6  0.4 4/6 0.2  0.0 5/6 0.7  0.5 5/5 0.9  0.7 11/11 1.5  0.8
Piriform Cortex 4/6 0.2  0.0 6/6 1.2  0.5 3/6 1.1  1.0 6/6 2.3  0.8 5/5 1.8  0.6 10/11 1.9  0.9
Thalamus 6/6 1.0  0.5 6/6 2.6  0.3 5/6 1.1  0.7 6/6 2.2  0.6 5/5 0.9  0.8 10/11 0.8  0.5
Cerebral Cortex 6/6 0.5  0.6 6/6 1.2  1.0 6/6 1.7  0.9 5/6 1.4  1.0 5/5 0.9  0.6 7/11 1.2  0.7
Substantia Nigra 3/6 1.4  0.8 1/6 0.2 (n = 1) 3/6 1.5  0.9 1/6 0.2 (n = 1) 1/5 1.2 (n = 1) 2/11 0.7  0.7
Caudate Putamen 0/6 n/a 1/6 0.2 (n = 1) 5/6 1.0  0.8 2/6 0.2  0.0 3/5 0.7  0.4 2/11 0.6  0.5
Lateral Ventricles 0/6 n/a 6/6 0.5  0.2 2/6 0.6  0.5 5/6 1.1  0.4 0/5 n/a 5/11 1.3  0.8
Incidence represents the fraction of animals with observable lesions at any given time post-DFP injection; severity, the average lesion severity score of animals with lesions at
any given time point presented as the mean  SD (animals without lesions were not included in the calculation of the average lesion severity score). N/A, no animals
presented with lesions at any given time point; (n = 1), data represents score from a single animal; *Includes only animals in Group 1; **, only animals in Group 2; *** Combined
data from Group 1 and Group 2.
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the dorsal aspect of the CA1 within the hippocampus (Fig. 1).
Overall, lesions were deﬁned by discrete, hyperintense foci with
deﬁned borders that initially expanded in area (became more
extensive) over time, and then later decreased in size (extent) and
intensity, and exhibited less deﬁned lesion borders.
At the earliest imaging time point (6 h post-DFP injection in
Group 1 animals), lesions were consistently observed within theFig. 3. Lesions detected by T2w MRI at 72 h post DFP intoxication correspond to regions o
control animal shows no T2w hyperintensity or FJC positive neurons in the hippocamp
hippocampus and piriform cortex that shows spatial registry to bands of FJC positive cthalamus and cerebral cortex, and more variably within the
piriform, globus pallidus and substantia nigra (Figs. 1 and 2, and
Table 1). When present, lesions were most extensive and intense in
the thalamus, followed by the substantia nigra, and were
comparatively less extensive and intense in the cerebral cortex,
piriform cortex, septal area, and amygdala. Lesions were notably
absent in the hippocampus, caudate putamen, and elsewhere in
the brain. Similarly, lesions at 12 h post-intoxication, the ﬁrstf ongoing neurodegeneration as assessed by FluoroJade C (FJC) staining. The vehicle
us or piriform cortex. In contrast, DFP intoxication produced hyperintensity in the
ells. Magniﬁcation: 100.
B.A. Hobson et al. / NeuroToxicology 66 (2018) 170–178 175imaging time point of Group 2 animals, were signiﬁcantly more
severe (p < 0.001) in the thalamus than in the piriform and
cerebral cortices. Lesions in these three brain regions were
signiﬁcantly more severe (p < 0.001) than the variable lesions in
the hippocampus. At the 12 h time point, ventriculomegaly was
also observed, which persisted in a subset of animals for the
remainder of the study (Table 1).
At subsequent time points, 18 h for Group 1 and 24 h for Group
2, lesions within the piriform cortex, hippocampus, cerebral cortex,
and thalamus either did not change or increased in extent and/or
severity, with the exception of decreased lesion severity in the
thalamus of Group 2 animals (p < 0.001). Strikingly, at 18 h post-
DFP injection, Group 1 animals developed signiﬁcant lesions
within the caudate putamen that were not observed in Group 2
animals at 24 h. By 48 h post intoxication, lesions in Group 1
animals were attenuated within the thalamus, caudate putamen,
and cerebral cortex, but increased in severity in the piriform cortex
and hippocampus. At 72 h, in both imaging groups, lesions were
common in the hippocampus, piriform cortex, and thalamus,
variably apparent in the cerebral cortex, and only occasionally
observed within the globus pallidus, substantia nigra and caudate
putamen (Table 1). Overall, lesion severity decreased across brain
regions by 72 h post-intoxication, with the marked exception of theFig. 4. Mixed-model regression from multiple brain regions demonstrate that the lesion 
Each progression curve is modeled on data from six animals from Group 1 (solid lines) or
the curves for each imaging group. Group 1 animals had signiﬁcantly lower lesion severi
study period (denoted with an “*”). Note: Group 1 animals received anesthesia 6 h earhippocampus, which showed increased lesion severity at 72 h
post-DFP injection (Table 1).
After imaging was completed at 72 h, animals were euthanized
to collect brains for histological conﬁrmation of neuropathology
using FJC staining. Consistent spatial registry was observed
between the location of hyperintense lesions in T2w images and
regions of neurodegeneration as determined by FJC staining
(Fig. 3): the piriform cortex (11/11), cerebral cortex (somatosenso-
ry) (11/11), hippocampus (CA1, CA3, dentate gyrus) (9/9), and
thalamus (9/9) (Fig. 3). Conversely, no FJC staining was observed in
regions in which no lesions were detected by MRI.
3.3. Quantitative analysis reveals that T2w MRI lesion severity varies
according to brain region, time post-exposure and group
To further characterize our observational ﬁndings, lesion
scoring in the hippocampus, thalamus, piriform and cerebral
cortices was subjected to mixed-model regression analysis.
Overall, average lesion severity varied signiﬁcantly between
imaging groups, brain regions and time post-exposure (Fig. 4).
With respect to inter-group differences, Group 1 had lower average
lesion severity scores over the study period than Group 2 in the
thalamus ((95% CI: 1.6, 0.5) and the piriform cortex (95% CI:severity changes over time in a brain-region and imaging group-dependent manner.
 six animals from Group 2 (dashed lines). 95% conﬁdence bands are included around
ty scores for the thalamus and piriform cortex than Group 2 animals over the entire
lier than Group 2 animals.
176 B.A. Hobson et al. / NeuroToxicology 66 (2018) 170–1781.3, 0.1); however, in all other brain regions, scores were similar
between imaging groups over time. In terms of spatiotemporal
variation, patterns were similar for the two imaging groups.
Lesions in the piriform cortex showed an initial increase in severity
(slope 95% CI: 1.4, 2.6); however, lesion severity eventually peaked
and then started to attenuate (time-squared 95% CI: 0.7, 0.4). A
similar, but less pronounced, pattern was observed in the cerebral
cortex (slope 95% CI: 0.3, 1.3; time-squared 95% CI: 0.5, 0.1).
Lesions in the thalamus did not change linearly over time (slope
95% CI: 0.4, 0.6), but, rather, experienced slight curvature (time-
squared 95% CI: 0.3, 0.02), suggesting lesion attenuation. In
contrast, lesion severity scores in the hippocampus showed no
evidence of curvature (time-squared 95% CI: 0.2, 0.2), but tended
to increase linearly over time, although the increase narrowly
missed statistical signiﬁcance (slope 95% CI: 0.02, 1.1).
4. Discussion
This study represents the most detailed MRI characterization to
date of the spatiotemporal progression of brain lesions during the
ﬁrst 72 h following acute OP intoxication. Our data demonstrate
that acute DFP intoxication in the rat produces hyperintense
lesions in T2w brain images that are detectable as early as 6 h post-
exposure, evolve in extent and intensity with time, and overlap
spatially to areas of histologically deﬁned neurodegeneration.
Lesion onset, severity and changes over time were found to be
region-dependent, and possibly inﬂuenced by the timing of
administration of isoﬂurane anesthesia.
T2w MRI of DFP-intoxicated animals revealed hyperintense
lesions characterized by region-dependent patterns of injury that
varied with respect to time-to-onset and pattern of progression.
Lesions were apparent as early as 6 h in the thalamus, substantia
nigra, and piriform and cerebral cortices while in the caudate
putamen and the hippocampus, the onset of injury was delayed
until 12 h post-intoxication. Longitudinal analysis of the earliest
lesions revealed that their hyperintensity began to attenuate
within 3 d post-exposure, while lesions in the hippocampus
continued to increase in extent and intensity throughout the 72 h
study. These spatiotemporal patterns of DFP-induced T2w lesions
are consistent with T2w MRI assessments of soman intoxication
in the rat and guinea pig, which reported that the thalamus and
piriform cortex were the most severely damaged regions at 3 and
6 h post-intoxication, respectively (Gullapalli et al., (2010), Shrot
et al., (2012)). Longitudinal analysis of T2w lesion severity in the
soman-intoxicated guinea pig (Gullapalli et al., 2010) also
demonstrated a delayed onset of more than 24 h in the
appearance of hippocampal hyperintensity relative to other
damaged regions.
The spatiotemporal distribution of lesions following DFP-
induced SE are similar to MRI assessments of other preclinical
seizure models, including pilocarpine (Duffy et al., (2014), Roch
et al., (2002), Suleymanova et al., (2016)), kainic acid (Liachenko
et al., (2015), Nakasu et al., (1995)), and electrical stimulation
(Nairismagi et al., 2004). Studies using these other seizure models
have focused on the hippocampus, piriform cortex, and thalamus,
and there are few reports of injury in the globus pallidus, caudate
putamen, and substantia nigra. However, it is unclear if the latter is
unique to our DFP model, or if evidence of damage to the globus
pallidus, caudate putamen, and substantia nigra are simply under
reported due to the early onset and resolution of T2w lesions in
these brain regions. Nonetheless, as suggested earlier (Hobson
et al., 2017), the commonalities in spatiotemporal patterns of brain
injury across preclinical models of SE that vary with respect to
model species and nature of the SE trigger, suggest that brain
lesions observed following acute DFP intoxication are primarily
due to prolonged seizure activity.While the etiology of lesions following DFP-induced SE is
unclear, contributing mechanisms likely include cerebral edema,
hypoxia and excitotoxicity. Previous MRI-based studies of convul-
sive OP intoxication using DFP or OP nerve agents have
demonstrated a high degree of spatial registry between T2w
hyperintense lesions and canonical signs of edema, including
transient increases in tissue-water content, restricted water
diffusion, tissue vacuolar changes, and subsequent brain atrophy
associated with lateral ventricle enlargement (Carpentier et al.,
(2008), Hobson et al., (2017), Rosman et al., (2012), Testylier et al.,
(2007)). Cerebral edema in preclinical models of SE and traumatic
brain injury (Bareyre et al., 1997), is characterized by acute
induction of ﬂuid accumulation occurring during the ﬁrst 24 to
72 h, followed by ﬂuid reabsorption, and then eventual tissue
atrophy over days to weeks (Bertoglio et al., (2017), Grohn and
Pitkanen, (2007)). Similarly, with the exception of the hippocam-
pus, brain lesions following DFP-induced SE initially expand then
recede coincident with the development of ventriculomegaly. The
T2w lesions observed following acute DFP intoxication are also
strikingly similar to those detected by MRI during the ﬁrst few
hours following hypoxia-ischemia in the rat (Farr and Wegener,
2010), and regional differences in tissue hypoxia may represent a
source of variation in spatiotemporal patterns of neuropathology
following DFP-induced SE. Collectively, observations in the rat
model of DFP-induced SE are consistent with the hypothesis that
neuropathology following SE in rats proceeds by excitotoxic and
ischemic mechanisms (Fabene et al., (2007), Puyal et al., (2013)).
Alternatively, the spatiotemporal patterns of lesions observed
following OP-induced SE may reﬂect secondary degeneration, a
phenomenon whereby neuronal damage is propagated along
speciﬁc anatomic routes deﬁned by neural circuits (Myhrer and
Aas, 2014). Our data are consistent with previous proposals that
early damage in the piriform cortex, which contains a well
characterized initiation site for SE, the area tempestas, triggers
delayed injury in the hippocampus via the perforant pathway
(Chen et al., (2014), McDonough and Shih, (1997), Siso et al.,
(2017)). Secondary degeneration may also explain our observation
that in DFP-intoxicated animals with lesions in the substantia nigra
at 6 h, hyperintensity is subsequently observed within the caudate
putamen at 18 h. The substantia nigra, like the area tempestas, is a
critical initiation point for generalized seizures (Gale, 1988), and,
like the piriform cortex, is damaged early following acute DFP
intoxication. The substantia nigra pars compacta projects extensive
dopaminergic connections to the caudate putamen via the
nigrostriatal pathway (Lanciego et al., 2012). Thus, damage to
the substantia nigra may trigger delayed lesions in the caudate
putamen. However, neuronal circuitry within the basal ganglia is
highly complex, and there are signiﬁcant connections between the
caudate putamen and not only the substantia nigra, but also the
thalamus, cerebral cortex, and globus pallidus (Lanciego et al.,
2012), all regions damaged early following DFP-induced SE. A more
granular proﬁle of the time course of damage in these brain regions
over the ﬁrst 12 h following DFP-induced SE may provide a better
understanding of these interactions.
An unexpected ﬁnding of this study was the difference in lesion
severity observed between the two imaging groups. While the
regional patterns of injury progression were the same in both
groups, lesion severity in the piriform cortex and thalamus was
signiﬁcantly reduced in Group 1 compared to Group 2. Both
imaging groups were subject to the same DFP intoxication
paradigm and experienced similar average cholinergic toxicity
scores. The primary difference between the groups was the timing
and summed duration of isoﬂurane anesthesia. Group 1 animals
received isoﬂurane anesthesia 6 h earlier than Group 2 animals,
and Group 1 animals were imaged over four sessions compared to
three sessions for Group 2. The signiﬁcantly reduced severity of
B.A. Hobson et al. / NeuroToxicology 66 (2018) 170–178 177lesions in Group 1 compared to Group 2 suggest a neuroprotective
effect from earlier initiation and/or increased total exposure to
anesthesia. Neuroprotective effects of isoﬂurane have been
demonstrated in preclinical models of stroke and traumatic brain
injury, as well as preclinical and clinical epilepsy (Bar-Klein et al.,
(2016), Gaidhani et al., (2017), Hertle et al., (2012), Zeiler et al.,
(2015)). Electroencephalographic characterization of mice acutely
intoxicated with soman demonstrated that isoﬂurane adminis-
tered for 90 min, beginning 3 h post-soman intoxication, effective-
ly terminates seizures for the duration of general anesthesia,
although SE recurred when isoﬂurane was discontinued (Testylier
et al., 2007). Nonetheless, soman-intoxicated animals that
received isoﬂurane exhibited less neuropathology within the
piriform cortex compared to un-anesthetized animals. Similarly,
our data indicate that isoﬂurane is neuroprotective in a preclinical
model of acute DFP intoxication, and suggest that: (i) the timing of
isoﬂurane anesthesia inﬂuences lesion severity, and/or (ii)
repeated doses as low as 2% isoﬂurane for 15 min can signiﬁcantly
affect the manifestation of injury.
In summary, our ﬁndings indicate that brain injury is apparent
by MRI within hours of DFP-induced SE, although the pattern of
injury varies by brain region. The neuroprotective effect of
isoﬂurane administered 6 h after DFP-induced SE suggests the
potential for delayed therapeutic interventions to mitigate
downstream neurological consequences, but also warns that
therapeutic interventions may vary regionally. Thus, while
structural changes in the brain may not capture all endpoints of
therapeutic relevance in OP-induced SE, our data support
longitudinal assessment of OP-induced damage by MRI as a
powerful tool for assessing not only OP-induced neuropathology,
but also therapeutic response.
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